Jiangsu Jibeier Pharmaceutical Co., Ltd. (688566.SS)
CNY 23.79
(-0.08%)
CNY 23.79
(-0.08%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 159.5 Million | 150.72 Million | 150.55 Million | 117.36 Million | 115.44 Million | 97.96 Million |
| Net Income | 218.76 Million | 154.26 Million | 114.34 Million | 129.85 Million | 112.78 Million | 96.91 Million |
| Depreciation & Amortization | 11.2 Million | 12.75 Million | 12.97 Million | 13.29 Million | 12.8 Million | 12.35 Million |
| Deferred income taxes | -689.74 Thousand | -472.03 Thousand | -802.95 Thousand | -4.39 Million | -325.42 Thousand | - |
| Stock-based compensation | 17.89 Million | 20.97 Million | 7.15 Million | - | - | - |
| Change in working capital | -99.24 Million | -33.94 Million | 33.84 Million | -11.82 Million | -11.34 Million | -9.75 Million |
| Other non-cash items | 1.17 Million | -3.38 Million | -16.96 Million | -13.97 Million | 1.19 Million | -1.55 Million |
| Investing Cash Flow | -364.03 Million | -175.49 Million | -333.14 Million | -5.8 Million | -29.54 Million | -5.28 Million |
| Investments in PPE | -357.37 Million | -292.7 Million | -83.78 Million | -23.68 Million | -30.21 Million | -8.19 Million |
| Acquisitions | - | 6000.00 | 582.11 | 600.00 | 2000.00 | - |
| Investment purchases | -70 Million | -11.2 Million | -60 Million | -2.46 Billion | -106.8 Million | - |
| Sales/Maturities of investments | 5.07 Million | 11.76 Million | 20.63 Million | 17.88 Million | 663.91 Thousand | 2.9 Million |
| Other Investing Activities | 58.25 Million | 116.63 Million | -209.99 Million | 2.46 Billion | 106.8 Million | 0.26 |
| Financing Cash Flow | -1.23 Million | -89.73 Million | -89.73 Million | 982.41 Million | -17.41 Million | -169.14 Million |
| Debt repayment | -19.74 Million | - | - | - | - | - |
| Dividends payments | -44.86 Million | -89.73 Million | -89.73 Million | -44.86 Million | -10.85 Million | -169.14 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -400 Thousand | - | - | -10.98 Million | -6.55 Million | - |
| Other Financing Activities | 43.63 Million | - | - | 1.02 Billion | -6.55 Million | -169.14 Million |
| Accounts receivables | -138.14 Million | -72.07 Million | 42.96 Million | -57.2 Million | -21.9 Million | -10.37 Million |
| Accounts payables | 38.46 Million | 39.43 Million | -8.59 Million | 52.68 Million | 8.55 Million | - |
| Inventory | 1.12 Million | -830.82 Thousand | 280.49 Thousand | -2.9 Million | 2.33 Million | -5.43 Million |
| Other working capital | 17.89 Million | -472.03 Thousand | -802.95 Thousand | -4.39 Million | -325.42 Thousand | -4.31 Million |
| Cash at beginning of period | 900.21 Million | 1.01 Billion | 1.28 Billion | 193.05 Million | 124.56 Million | 201.03 Million |
| Cash at end of period | 694.44 Million | 900.21 Million | 1.01 Billion | 1.28 Billion | 193.05 Million | 124.56 Million |
| Capital Expenditure | -357.37 Million | -292.7 Million | -83.78 Million | -23.68 Million | -30.21 Million | -8.19 Million |
| Effect of forex changes on cash | - | 0.86 | - | 1.04 | -0.72 | 0.33 |
| Net cash flow / Change in cash | -205.77 Million | -114.49 Million | -272.32 Million | 1.09 Billion | 68.48 Million | -76.46 Million |
| Free Cash Flow | -197.87 Million | -141.98 Million | 66.77 Million | 93.68 Million | 85.23 Million | 89.77 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 52.55 Million | 69.49 Million | 52.51 Million | 60.8 Million | 218.76 Million | 58.8 Million |
| Depreciation & Amortization | - | 2.92 Million | 2.92 Million | 11.2 Million | 11.2 Million | -5.78 Million |
| Deferred income taxes | - | - | - | - | -689.74 Thousand | -53.7 Million |
| Stock-based compensation | - | 2.34 Million | - | 17.89 Million | 17.89 Million | -10.54 Million |
| Change in working capital | - | -24.59 Million | - | -119.13 Million | -99.24 Million | 70.04 Million |
| Other non-cash items | -12.54 Million | -15.49 Million | 29.67 Million | -60.8 Million | 1.17 Million | -72.59 Million |
| Investing Cash Flow | -227.28 Million | 106.28 Million | -303.77 Million | 103.06 Million | -364.03 Million | -236.17 Million |
| Investments in PPE | -32.52 Million | -53.52 Million | -43.77 Million | -99.83 Million | -357.37 Million | -61.37 Million |
| Acquisitions | - | - | - | - | - | -225.93 Million |
| Investment purchases | 504 Million | -504 Million | - | -584.93 Million | -70 Million | 225.93 Million |
| Sales/Maturities of investments | 1.23 Million | 404 Million | 280.59 Thousand | 2.9 Million | 5.07 Million | 204.99 Thousand |
| Other Investing Activities | -196 Million | 259.81 Million | -260 Million | 200 Million | 58.25 Million | -175 Million |
| Financing Cash Flow | -17.5 Million | 195.63 Million | 9.55 Million | 9.57 Million | -1.23 Million | 24.58 Million |
| Debt repayment | - | - | - | -19.74 Million | -19.74 Million | - |
| Dividends payments | - | - | - | - | -44.86 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | -400 Thousand | -400 Thousand | - |
| Other Financing Activities | -17.5 Million | 195.63 Million | 9.55 Million | 9.57 Million | 43.63 Million | 24.58 Million |
| Accounts receivables | - | -28.25 Million | - | -138.14 Million | -138.14 Million | 69.91 Million |
| Accounts payables | - | - | - | - | 38.46 Million | 10.81 Million |
| Inventory | - | -1.42 Million | - | 1.12 Million | 1.12 Million | 129.29 Thousand |
| Other working capital | - | 5.08 Million | - | 17.89 Million | 17.89 Million | -10.81 Million |
| Cash at beginning of period | 835.41 Million | 482.84 Million | 694.44 Million | 517.84 Million | 900.21 Million | 743.42 Million |
| Cash at end of period | 629.39 Million | 836.03 Million | 482.84 Million | 694.44 Million | 694.44 Million | 517.84 Million |
| Capital Expenditure | -32.52 Million | -53.52 Million | -43.77 Million | -99.83 Million | -357.37 Million | -61.37 Million |
| Effect of forex changes on cash | - | - | - | - | - | -204.99 Thousand |
| Net cash flow / Change in cash | -206.02 Million | 353.18 Million | -211.59 Million | 176.59 Million | -205.77 Million | -225.57 Million |
| Free Cash Flow | 7.48 Million | -2.45 Million | 38.41 Million | -35.88 Million | -197.87 Million | -75.16 Million |
0QM4
5194
SRN
7277
DRX
3277